The invention provides a method of treating hypertension, particularly in individuals that have experienced intrauterine fetal programming or an adverse post-natal environment. The method comprises administering an agent which is a ligand that binds to and activates the growth hormone receptor. Preferably, growth hormone, an analog thereof or a functionally equivalent ligand is administered.
